JP

Satoru Saito

This inventor holds 0 USPTO granted patents, plus 5 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoru Saito. Retrieved from https://idiyas.com/inventor/satoru-saito-6k0hhnd1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Satoru Saito - Innovator in NK Cell Amplification

Introduction

Satoru Saito is a notable inventor based in Japan, recognized for his contributions to the field of immunotherapy. His innovative work focuses on the amplification of natural killer (NK) cells, which are crucial for adoptive immunotherapy treatments.

Latest Patents

Saito has developed a method for amplifying NK cells in vitro, which is essential for preparing an optimal number of NK cells for therapeutic applications. This method involves preparing a cell population comprised of NK cells, removing T cells from this population, and cultivating the remaining cells in a medium supplemented with 2500 to 2831 IU/mL of IL-2. Although he currently holds 0 patents, his research has significant implications for the future of immunotherapy.

Career Highlights

Satoru Saito has worked with prominent institutions such as Kyushu University and Gaia Biomedicine Inc. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Saito has collaborated with notable colleagues, including Yoshikazu Yonemitsu and Yui Harada. These partnerships have enriched his research endeavors and fostered innovation in the field.

Conclusion

Satoru Saito's work in amplifying NK cells represents a significant advancement in immunotherapy. His innovative methods and collaborations highlight his commitment to improving therapeutic techniques for better patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…